Guaifenesin and Dextromethorphan HBr
NDC 63304-106, Guaifenesin and Dextromethorphan HBr, tablet, extended release, from SUN PHARMACEUTICAL INDUSTRIES, INC..
- Product NDC
- 63304-106
- Status
- Listed
- Labeler
- SUN PHARMACEUTICAL INDUSTRIES, INC.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA214781
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63304-106 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUAIFENESIN600 mg/1
- DEXTROMETHORPHAN HYDROBROMIDE30 mg/1
Pharmacologic classes
Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; Sigma-1 Agonist [EPC]; Sigma-1 Receptor Agonists [MoA]; Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]; Uncompetitive NMDA Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63304-106-21 | 63304010621 | 1 BLISTER PACK in 1 CARTON (63304-106-21) / 20 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 63304-106 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63304-106 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63304-106. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.